A TMEFF2-regulated cell cycle derived gene signature is prognostic of recurrence risk in prostate cancer

A TMEFF2-regulated cell cycle derived gene signature is prognostic of recurrence risk in prostate cancer

Abstract Background The clinical behavior of prostate cancer (PCa) is variable, and while the majority of cases remain indolent, 10% of patients progress to deadly forms of the disease. Current clinical predictors used at the time of diagnosis have limitations to accurately establish progression ris...

Full description

Bibliographic Details
Main Authors: Constantin Georgescu, Joshua M. Corbin, Sandra Thibivilliers, Zachary D. Webb, Yan D. Zhao, Jan Koster, Kar-Ming Fung, Adam S. Asch, Jonathan D. Wren, Maria J. Ruiz-Echevarría
Format: Article
Language:English
Published: BMC 2019-05-01
Series:BMC Cancer
Subjects:
Prostate cancer
Prognostic markers
Cell cycle genes
Risk stratification
TMEFF2
Online Access:http://link.springer.com/article/10.1186/s12885-019-5592-6

Internet

http://link.springer.com/article/10.1186/s12885-019-5592-6

Similar Items